Literature DB >> 6405965

Alpha blockers and converting enzyme inhibitors.

P K Marrott, M Cohen.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6405965      PMCID： PMC1548210          DOI： 10.1136/bmj.286.6379.1749-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Indoramin and prazosin as adjuncts to beta adrenoceptor blockade in hypertension.

Authors:  G S Stokes; G W Frost; R M Graham; E P MacCarthy
Journal:  Clin Pharmacol Ther       Date:  1979-06       Impact factor: 6.875

2.  Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness.

Authors:  C de White; R B Royds; P Turner
Journal:  Postgrad Med J       Date:  1974-12       Impact factor: 2.401

3.  Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.

Authors:  R Kramer; C Rosendorff; D Bloom
Journal:  S Afr Med J       Date:  1974-08-03

4.  The treatment of arterial hypertension with a new alpha-blocker, indoramin.

Authors:  R Carballo; L Conde; M Lapelle; J Suarez
Journal:  Curr Med Res Opin       Date:  1974       Impact factor: 2.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.